Multiple studies have shown that DKC1 is upregulated in colorectal cancer, prostate cancer, breast cancer, and other cancers, indicating that DKC1 upregulation may be a common feature of invasive cancer 42, 42. This evidence concerns the gene DKC1 and prostate carcinoma.